Ideal Power Inc. — Q2 2023 Form 10-Q
Business and period: Unaudited results for the three and six months ended June 30, 2023. Austin-based Ideal Power is developing and commercializing its B-TRAN solid-state switch technology; it remains pre-commercial, with revenue primarily from grants and development work.
Financial performance and position
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Revenue | $135,167 | $50,978 | $135,831 | $175,986 |
| Gross profit | $24,430 | $0 | $24,430 | $0 |
| Operating expenses | $2,412,581 | $1,696,172 | $5,051,868 | $3,597,097 |
| Operating loss | $2,388,151 | $1,696,172 | $5,027,438 | $3,597,097 |
| Net loss | $2,279,806 | $1,689,994 | $4,807,791 | $3,594,635 |
| Net loss per share | $0.37 | $0.27 | $0.78 | $0.58 |
Q2 2023 revenue included $98,443 of development revenue and $36,724 of grant revenue. Grant revenue is matched by associated costs, producing no gross profit; the period’s gross profit came from the development agreement. Six-month revenue fell as prior-year grant work concluded. Higher research and development, general and administrative, and sales and marketing expenses drove larger operating and net losses. Net interest income rose to $108,345 for Q2 and $219,647 for the six-month period, primarily due to higher interest rates.
At June 30, 2023, cash and equivalents were $12.68 million, down from $16.35 million at year-end 2022. Six-month operating cash outflow was $3.41 million, versus $3.08 million in 2022; investing outflow was $254,000, versus $68,000. Total assets were $16.48 million, total liabilities $2.14 million, and stockholders’ equity $14.33 million. The company reported no outstanding debt. Net working capital was $12.6 million. Cash covered current liabilities of $794,000 by a wide margin, though operations continue to consume cash.
Changes, outlook and risks
- Q2 revenue rose year over year, but six-month revenue declined. Q2 operating expenses increased 42% and net loss increased 35% year over year; six-month operating expenses rose 40% and net loss rose 34%.
- Ideal Power launched its SymCool Power Module in January 2023 and expected fabrication and initial sales later in 2023. Management also expected a second commercial product launch in the second half of 2023. These are expectations, not confirmed sales results.
- The company began shipments to customer test-and-evaluation program participants in June. Phase 1 work for a top-10 global automaker generated nearly all Q2 development revenue. Phase 2 remains conditional on successful Phase 1; production-ready modules are targeted for 2025.
- The $1.2 million DTI/NAVSEA subcontract was completed in June 2023. Management expects higher R&D spending and operating cash outflows in the remainder of 2023 as commercialization proceeds; sales and marketing costs are also expected to rise. G&A excluding stock compensation was expected to be flat to modestly lower.
- Management believed cash on hand would fund ongoing liquidity needs for at least 12 months from the filing date, but may need additional financing to fully implement its plans. Future financing availability and terms are not assured. Commercialization, customer adoption, product performance, fabrication timing, partnerships, intellectual-property protection, and cash management are key risks.
- License agreements create estimated future-payment liabilities: other long-term liabilities were $1.18 million at June 30, including annual license-payment commitments. The filing reports no current legal proceedings and no material changes to previously disclosed risk factors. Disclosure controls were assessed as effective.
Important facts for investors to verify
- Whether SymCool fabrication, commercial sales, and the second product launch occurred on the expected schedule, and whether meaningful revenue followed.
- Progress and customer decisions in test programs, especially the automaker’s Phase 1 evaluation and any award of Phase 2.
- Cash burn, remaining liquidity runway, and whether the company requires new equity, debt, grants, or partnership funding.
- R&D and commercialization spending trends, including stock-based compensation and the effect of fabrication costs on reported losses.
- Timing and amount of license-payment obligations, and potential dilution from outstanding warrants, options, and equity awards.